<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0021">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Mehndiratta</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>RS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Huang</surname>
    <given-names>HL</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC Class I and IIB inhibitors in vitro and in vivo</article-title>. 
  <source>Eur J Med</source>
  <source>Chem</source>
  <year>2017</year>;
  <volume>134</volume>:
  <fpage>13</fpage>–
  <lpage>23</lpage>.
 </mixed-citation>
</ref>
